Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1540–1543. [PubMed] [Google Scholar]
- Ingham H. R., Rich G. E., Selkon J. B., Hale J. H., Roxby C. M., Betty M. J., Johnson R. W., Uldall P. R. Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis. J Antimicrob Chemother. 1975 Jun;1(2):235–242. doi: 10.1093/jac/1.2.235. [DOI] [PubMed] [Google Scholar]
- Ramsay I. D. Endocrine ophthalmopathy. Br Med J. 1968 Dec 14;4(5632):706–706. doi: 10.1136/bmj.4.5632.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tally F. P., Sutter V. L., Finegold S. M. Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med. 1972 Dec;117(6):22–26. [PMC free article] [PubMed] [Google Scholar]
- Ursing B., Kamme C. Metronidazole for Crohn's disease. Lancet. 1975 Apr 5;1(7910):775–777. doi: 10.1016/s0140-6736(75)92438-1. [DOI] [PubMed] [Google Scholar]